The applicability of home blood pressure measurement in clinical practice: A review of literature

Vascular Health and Risk Management

Volumn 3, Issue 6, 2007, Pages 959-966

  Verberk, Willem J ^a   Kroon, Abraham A ^a   Jongen Vancraybex, Heidi A ^a   de Leeuw, Peter W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Ambulatory measurement; Blood pressure; Home measurement; Hypertension; Self measurement

Indexed keywords

ANTIHYPERTENSIVE AGENT; LOSARTAN;

AGING; AMBULATORY MONITORING; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; HEALTH CARE SYSTEM; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MASKED HYPERTENSION; MONOTHERAPY; MORTALITY; PATIENT COMPLIANCE; PREVALENCE; PROGNOSIS; REPRODUCIBILITY; REVIEW; RISK FACTOR; SELF EXAMINATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 38149004233     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Ashida T, Sugiyama T, Okuno S, et al. 2000. Relationship between home blood pressure measurement and medication compliance and name recognition of antihypertensive drugs. Hypertens Res, 23:21-4.
2. Battig B, Steiner A, Jeck T, et al. 1989. Blood pressure self-measurement in normotensive and hypertensive patients. J Hypertens Suppl, 7:S59-63.
3. Bjorklund K, Lind L, Zethelius B, et al. 2003. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation, 107:297-302.
4. Bobrie G, Chatellier G, Genes N, et al. 2004. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA, 291:1342-9.
5. Bobrie G, Genes N, Vaur L, et al. 2001. Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk? Arch Intern Med, 161:2205-11.
6. Brook RD. 2000. Home blood pressure: accuracy is independent of monitoring schedules. Am J Hypertens, 13:625-31.
7. Cappuccio FP, Kerry SM, Forbes L, et al. 2004. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ, 329:145.
8. Celis H, De Cort P, Fagard R, et al. 1997. For how many days should blood pressure be measured at home in older patients before steady levels are obtained? J Hum Hypertens, 11:673-7.
9. Chonan K, Kikuya M, Araki T, et al. 2001. Device for the self-measurement of blood pressure that can monitor blood pressure during sleep. Blood Press Monit, 6:203-5.
10. Cuspidi C, Macca G, Michev I, et al. 2002. Left ventricular concentric remodelling and extracardiac target organ damage in essential hypertension. J Hum Hypertens, 16:385-90.
11. De Gaudemaris R, Chau NP, Mallion JM. 1994. Home blood pressure: variability, comparison with office readings and proposal for reference values. Groupe de la Mesure, French Society of Hypertension. J Hypertens, 12:831-8.
12. Fagard RH, Van Den Broeke C, De Cott P. 2005. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens, 19:801-7.
13. Fernandez-Gonzalez R, Gomez-Pajuelo C, Gabriel R, et al. 2000. Effect of verapamil on home self-measurement of blood pressure and heart rate by hypertensive patients. Verapamil-Frequency Research Group. Blood Press Monit, 5:23-30.
14. Garcia-Vera MP, Sanz J. 1999. How many self-measured blood pressure readings are needed to estimate hypertensive patients' "true" blood pressure? J Behav Med, 22:93-113.
15. Guidelines Subcommittee. 1999. World Health Organization-Intemational Society of Hypertension guidelines for the management of hypertension. J Hypertens, 17:151-83.
16. Imai Y, Nishiyama A, Sekino M, et al. 1999. Characteristics of blood pressure measured at home in the morning and in the evening: the Ohasama study. J Hypertens, 17:889-98.
17. Imai Y, Satoh H, Nagai K, et al. 1993. Characteristics of a community-based distribution of home blood pressure in Ohasama in northern Japan. J Hypertens, 11:1441-9.
18. Johnson KA, Partsch DJ, Rippole LL, et al. 1999. Reliability of self-reported blood pressure measurements. Arch Intern Med, 159:2689-93.
19. Jula A, Puukka P, Karanko H. 1999. Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring. Hypertension, 34:261-6.
20. Kario K, Shimada K, Pickering TG. 2003. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol, 42 Suppl 1:S87-91.
21. Leeman MJ, Lins RL, Sternon JE, et al. 2000. Effect of antihypertensive treatment on office and self-measured blood pressure: the Autodil study. J Hum Hypertens, 14:525-9.
22. Mancia G, Facchetti R, Bombelli M, et al. 2006. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension, 47:846-53.
23. Mancia G, Sega R, Bravi C, et al. 1995. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens, 13:1377-90.
24. Mancia G, Sega R, Grassi G, et al. 2001. Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. J Hypertens, 19:995-9.
25. Mansoor GA, McCabe EJ, White WB. 1996. Determinants of the white-coat effect in hypertensive subjects. J Hum Hypertens, 10:87-92.
26. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, et al. 2006. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens, 24:169-75.
27. Menard J, Chatellier G, Day M, et al. 1994. Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio. J Hypertens Suppl, 12:S21-5.
28. Mule G, Caimi G, Cottone S, et al. 2002. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J cardiovasc risk, 9:123-9.
29. Ohkubo T, Imai Y, Tsuji I, et al. 1998. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens, 16:971-5.
30. Ohkubo T, Kikuya M, Metoki H, et al. 2005. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol, 46:508-15.
31. Pickering TG, Davidson K, Gerin W, et al. 2002. Masked hypertension. Hypertension, 40:795-6.
32. Pickering TG, Gerin W, Schwartz AR. 2002. What is the white-coat effect and how should it be measured? Blood Press Monit, 7:293-300.
33. Staessen JA, Den Hond E, Celis H, et al. 2004. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA, 291:955-64.
34. Stergiou GS, Efstathiou SP, Argyraki CK, et al. 2004. White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoring. Am J Hypertens, 17:124-8.
35. Stergiou GS, Efstathiou SP, Skeva II, et al. 2002. Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements. J Hum Hypertens, 16:729-35.
36. Stergiou GS, Skeva II, Zourbaki AS, et al. 1998. Self-monitoring of blood pressure at home: how many measurements are needed? J Hypertens, 16:725-31.
37. Stergiou GS, Thomopoulou GC, Skeva II, et al. 2000. Home blood pressure normalcy: the Didima study. Am J Hypertens, 13:678-85.
38. Stergiou GS, Zourbaki AS, Skeva II, et al. 1998. White coat effect detected using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure. Am J Hypertens, 11:820-7.
39. Thijs L, Staessen JA, Celis H, et al. 1998. Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med, 158:481-8.
40. Thijs L, Staessen JA, Celis H, et al. 1999. The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit, 4:77-86.
41. Tsai PS. 2003. Determinants of the white-coat effect in normotensives and never-treated mild hypertensives. Clin Exp Hypertens, 25:443-54.
42. Tsuji I, Imai Y, Nagai K, et al. 1997. Proposal of reference values for home blood pressure measurement: prognostic criteria based on a prospective observation of the general population in Ohasama, Japan. Am J Hypertens, 10:409-18.
43. Tsunoda S, Kawano Y, Horio T, et al. 2002. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res, 25:167-73.
44. Ugajin T, Hozawa A, Ohkubo T, et al. 2005. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med, 165:1541-6.
45. Vaur L, Dubroca II, Dutrey-Dupagne C, et al. 1998. Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs. Blood Press Monit, 3:107-14.
46. Verberk WJ, Kroon AA, Kessels AG, et al. 2005. Home blood pressure measurement a systematic review. J Am Coll Cardiol, 46:743-51.
47. Vetter W, Hess L, Brignoli R. 2000. Influence of self-measurement of blood pressure on the responder rate in hypertensive patients treated with losartan: results of the SVATCH Study. Standard vs Automatic Treatment Control of COSAAR in Hypertension. J Hum Hypertens, 14:235-41.
48. Weisser B, Grune S, Burger R, et al. 1994. The Dubendorf Study: a population-based investigation on normal values of blood pressure self-measurement. J Hum Hypertens, 8:227-31.
49. Weisser B, Mengden T, Dusing R, et al. 2000. Normal values of blood pressure self-measurement in view of the 1999 World Health Organization-International Society of Hypertension guidelines. Am J Hypertens, 13:940-3.
50. Zakopoulos NA, Kotsis VT, Pitiriga V, et al. 2002. White-coat effect in normotension and hypertension. Blood Press Monit, 7:271-6.
51. Zannad F, Vaur L, Dutrey-Dupagne C, et al. 1996. Assessment of drug efficacy using home self-blood pressure measurement: the SMART study. Self measurement for the assessment of the response to trandolapril. J Hum Hypertens, 10:341-7.